Cargando…

1543. The More Resistant, the More Fatal: Results of 414 Bacteremia Episodes in Febril Neutropenic Patients

BACKGROUND: The objective of this study was to investigate the features of antimicrobial resistance in the microorganisms isolated from blood cultures of cases with FN and the relationship between resistance and mortality rates. METHODS: We conducted a single-centre retrospective surveillance study...

Descripción completa

Detalles Bibliográficos
Autores principales: Surme, Serkan, Ozdemir, Yusuf E, Sahin, Meryem, Balkan, Ilker I, Mete, Bilgul, Can, Gunay, Tabak, Fehmi, Saltoglu, Nese
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6254083/
http://dx.doi.org/10.1093/ofid/ofy210.1371
_version_ 1783373642232496128
author Surme, Serkan
Ozdemir, Yusuf E
Sahin, Meryem
Balkan, Ilker I
Mete, Bilgul
Can, Gunay
Tabak, Fehmi
Saltoglu, Nese
author_facet Surme, Serkan
Ozdemir, Yusuf E
Sahin, Meryem
Balkan, Ilker I
Mete, Bilgul
Can, Gunay
Tabak, Fehmi
Saltoglu, Nese
author_sort Surme, Serkan
collection PubMed
description BACKGROUND: The objective of this study was to investigate the features of antimicrobial resistance in the microorganisms isolated from blood cultures of cases with FN and the relationship between resistance and mortality rates. METHODS: We conducted a single-centre retrospective surveillance study of hospitalized cases with FN who had bloodstream infection (BSI) between 2012 and 2016. Organisms were identified according to current conventional procedures. RESULTS: We determined 414 episodes of BSI in 252 patients of whom 53.6% were male and median age was 50 years. Distribution of common microorganisms causing BSI is presented in Figure 1. Rates and patterns of resistant microorganisms are presented in Table 1 and Figure 2. Catheter-related bacteremia constituted 49.8% (206/414) of total episodes and 30-day mortality was significantly lower (P < 0.007) in this group. In total, 30-day crude mortality rate was 14.7% (61/414 episodes). The mortality rates were 7.4, 18.6, 32.4 and 50% in BSI episodes due to Gram-positive, Gram-negative bacterial, polymicrobial and fungal etiology, respectively. Among Gram-negatives 30-day mortality was significantly associated with the presence of resistance; extended-spectrum β-lactamase (ESBL) (P = 0.006), carbapenem resistance (P < 0.0001), piperacillin/tazobactam resistance (P < 0.0001) and colistin resistance (P = 0.009). Among Gram-positives 30-day mortality was not associated with presence of resistance. CONCLUSION: The rate of carbapenem and colistin resistance has increased over the years. Changing antimicrobial resistance pattern particularly in Gram negatives is among the most decisive parameters for the success of empirical treatment and antimicrobial stewardship. DISCLOSURES: All authors: No reported disclosures.
format Online
Article
Text
id pubmed-6254083
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-62540832018-11-28 1543. The More Resistant, the More Fatal: Results of 414 Bacteremia Episodes in Febril Neutropenic Patients Surme, Serkan Ozdemir, Yusuf E Sahin, Meryem Balkan, Ilker I Mete, Bilgul Can, Gunay Tabak, Fehmi Saltoglu, Nese Open Forum Infect Dis Abstracts BACKGROUND: The objective of this study was to investigate the features of antimicrobial resistance in the microorganisms isolated from blood cultures of cases with FN and the relationship between resistance and mortality rates. METHODS: We conducted a single-centre retrospective surveillance study of hospitalized cases with FN who had bloodstream infection (BSI) between 2012 and 2016. Organisms were identified according to current conventional procedures. RESULTS: We determined 414 episodes of BSI in 252 patients of whom 53.6% were male and median age was 50 years. Distribution of common microorganisms causing BSI is presented in Figure 1. Rates and patterns of resistant microorganisms are presented in Table 1 and Figure 2. Catheter-related bacteremia constituted 49.8% (206/414) of total episodes and 30-day mortality was significantly lower (P < 0.007) in this group. In total, 30-day crude mortality rate was 14.7% (61/414 episodes). The mortality rates were 7.4, 18.6, 32.4 and 50% in BSI episodes due to Gram-positive, Gram-negative bacterial, polymicrobial and fungal etiology, respectively. Among Gram-negatives 30-day mortality was significantly associated with the presence of resistance; extended-spectrum β-lactamase (ESBL) (P = 0.006), carbapenem resistance (P < 0.0001), piperacillin/tazobactam resistance (P < 0.0001) and colistin resistance (P = 0.009). Among Gram-positives 30-day mortality was not associated with presence of resistance. CONCLUSION: The rate of carbapenem and colistin resistance has increased over the years. Changing antimicrobial resistance pattern particularly in Gram negatives is among the most decisive parameters for the success of empirical treatment and antimicrobial stewardship. DISCLOSURES: All authors: No reported disclosures. Oxford University Press 2018-11-26 /pmc/articles/PMC6254083/ http://dx.doi.org/10.1093/ofid/ofy210.1371 Text en © The Author(s) 2018. Published by Oxford University Press on behalf of Infectious Diseases Society of America. http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited. For commercial re-use, please contact journals.permissions@oup.com
spellingShingle Abstracts
Surme, Serkan
Ozdemir, Yusuf E
Sahin, Meryem
Balkan, Ilker I
Mete, Bilgul
Can, Gunay
Tabak, Fehmi
Saltoglu, Nese
1543. The More Resistant, the More Fatal: Results of 414 Bacteremia Episodes in Febril Neutropenic Patients
title 1543. The More Resistant, the More Fatal: Results of 414 Bacteremia Episodes in Febril Neutropenic Patients
title_full 1543. The More Resistant, the More Fatal: Results of 414 Bacteremia Episodes in Febril Neutropenic Patients
title_fullStr 1543. The More Resistant, the More Fatal: Results of 414 Bacteremia Episodes in Febril Neutropenic Patients
title_full_unstemmed 1543. The More Resistant, the More Fatal: Results of 414 Bacteremia Episodes in Febril Neutropenic Patients
title_short 1543. The More Resistant, the More Fatal: Results of 414 Bacteremia Episodes in Febril Neutropenic Patients
title_sort 1543. the more resistant, the more fatal: results of 414 bacteremia episodes in febril neutropenic patients
topic Abstracts
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6254083/
http://dx.doi.org/10.1093/ofid/ofy210.1371
work_keys_str_mv AT surmeserkan 1543themoreresistantthemorefatalresultsof414bacteremiaepisodesinfebrilneutropenicpatients
AT ozdemiryusufe 1543themoreresistantthemorefatalresultsof414bacteremiaepisodesinfebrilneutropenicpatients
AT sahinmeryem 1543themoreresistantthemorefatalresultsof414bacteremiaepisodesinfebrilneutropenicpatients
AT balkanilkeri 1543themoreresistantthemorefatalresultsof414bacteremiaepisodesinfebrilneutropenicpatients
AT metebilgul 1543themoreresistantthemorefatalresultsof414bacteremiaepisodesinfebrilneutropenicpatients
AT cangunay 1543themoreresistantthemorefatalresultsof414bacteremiaepisodesinfebrilneutropenicpatients
AT tabakfehmi 1543themoreresistantthemorefatalresultsof414bacteremiaepisodesinfebrilneutropenicpatients
AT saltoglunese 1543themoreresistantthemorefatalresultsof414bacteremiaepisodesinfebrilneutropenicpatients